Lcz696?

Report





Upload Image







Report Form



Question: Lcz696?

Topics: lcz696

Paste old question below.


Available Answers: 1


Answer #1#

21


Sacubitril/valsartan, sold under the brand name Entresto among others, is a combination drug for use in heart failure. LCZ696 (sacubitril/valsartan) is a member of a new class of agents called angiotensin receptor-neprilysin inhibitors (ARNIs) which combine a neprilysin inhibitor and angiotensin receptor blocker (ARB). [51] LCZ696 (Entresto™, Novartis) is a first-in-class angiotensin II receptor-neprilysin inhibitor (ARNI) whose multimodal mode of action involves neprilysin inhibition and AT1 receptor blockade. Sacubitril/valsartan (formerly known as LCZ696) is a first-in-class angiotensin receptor neprilysin inhibitor (ARNI) that simultaneously suppresses RAAS. To assess benefits and harms of first-in-class angiotensin receptor-neprilysin inhibitor sacubitril/valsartan (LCZ696) as compared to. The objectives are as follows: To assess benefits and harms of first‐in‐class angiotensin receptor‐neprilysin inhibitor sacubitril/valsartan (LCZ696).

Report

Answered By:
Mishka

Mishka

San Diego, United States

Only Logged in users can post reply.


More Questions


Login


Lost Password!

Create Account

Wait Processing...